Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline
Practical Radiation Oncology · 2024-03 · 14 (2) · 112-132
DOI: 10.1016/j.prro.2023.11.001 ↗Kurz gefasst
Leitlinie in der Zeitschrift Practical Radiation Oncology, 2024-03. Verfasst von Simona F Shaitelman und 18 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast Radiation Oncology, University of Texas MD - Anderson Cancer Center, Houston, Texas. Electronic address: sfshaitelman@mdanderson…. Hauptthemen laut MEDLINE: Brachytherapy, Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Radiotherapy, Conformal. Die Arbeit wurde bisher 185-mal zitiert (Crossref) und nennt 81 Literaturangaben. Gefördert von: American Society for Radiation Oncology, Patient-Centered Outcomes Research Institute, Agency for Healthcare Research and Quality.
Abstract (Originalsprache)
PURPOSE: This guideline provides evidence-based recommendations on appropriate indications and techniques for partial breast irradiation (PBI) for patients with early-stage invasive breast cancer and ductal carcinoma in situ. METHODS: ASTRO convened a task force to address 4 key questions focused on the appropriate indications and techniques for PBI as an alternative to whole breast irradiation (WBI) to result in similar rates of ipsilateral breast recurrence (IBR) and toxicity outcomes. Also addressed were aspects related to the technical delivery of PBI, including dose-fractionation regimens, target volumes, and treatment parameters for different PBI techniques. The guideline is based on a systematic review provided by the Agency for Healthcare Research and Quality. Recommendations were created using a predefined consensus-building methodology and system for grading evidence quality and recommendation strength. RESULTS: PBI delivered using 3-dimensional conformal radiation therapy, intensity modulated radiation therapy, multicatheter brachytherapy, and single-entry brachytherapy results in similar IBR as WBI with long-term follow-up. Some patient characteristics and tumor features were underrepresented in the randomized controlled trials, making it difficult to fully define IBR risks for patients with these features. Appropriate dose-fractionation regimens, target volume delineation, and treatment planning parameters for delivery of PBI are outlined. Intraoperative radiation therapy alone is associated with a higher IBR rate compared with WBI. A daily or every-other-day external beam PBI regimen is preferred over twice-daily regimens due to late toxicity concerns. CONCLUSIONS: Based on published data, the ASTRO task force has proposed recommendations to inform best clinical practices on the use of PBI.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Breast Radiation Oncology, University of Texas MD - Anderson Cancer Center, Houston, Texas. Electronic address: sfshaitelman@mdanderson.org.
- Department of Radiation Oncology, University of Wisconsin, Madison, Wisconsin.
- Department of Radiation Oncology, Virginia Commonwealth University, Richmond, Virginia.
- Department of Radiation Oncology, City of Hope Comprehensive Cancer Center, Duarte, California.
- Department of Radiation Oncology, Dana-Farber Cancer Institute and Brigham and Women's Hospital, Boston, Massachusetts.
- American Society for Radiation Oncology, Arlington, Virginia.
Förderung
- American Society for Radiation Oncology
- Patient-Centered Outcomes Research Institute
- Agency for Healthcare Research and Quality
Zitieren
APA
Shaitelman, S. F., Anderson, B. M., Arthur, D. W., Bazan, J. G., Bellon, J. R., Bradfield, L., Coles, C. E., Gerber, N. K., Kathpal, M., Kim, L., Laronga, C., Meattini, I., Nichols, E. M., Pierce, L. J., Poppe, M. M., Spears, P. A., Vinayak, S., Whelan, T., & Lyons, J. A. (2024). Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology, 14(2), 112-132. https://doi.org/10.1016/j.prro.2023.11.001
Vancouver
Shaitelman SF, Anderson BM, Arthur DW, Bazan JG, Bellon JR, Bradfield L, et al. Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline. Practical Radiation Oncology. 2024;14(2):112-132. doi:10.1016/j.prro.2023.11.001
BibTeX
@article{Shaitelman2024,
author = {Shaitelman, Simona F and Anderson, Bethany M and Arthur, Douglas W and Bazan, Jose G and Bellon, Jennifer R and Bradfield, Lisa and Coles, Charlotte E and Gerber, Naamit K and Kathpal, Madeera and Kim, Leonard and Laronga, Christine and Meattini, Icro and Nichols, Elizabeth M and Pierce, Lori J and Poppe, Matthew M and Spears, Patricia A and Vinayak, Shaveta and Whelan, Timothy and Lyons, Janice A},
title = {Partial Breast Irradiation for Patients With Early-Stage Invasive Breast Cancer or Ductal Carcinoma In Situ: An ASTRO Clinical Practice Guideline},
journal = {Practical Radiation Oncology},
year = {2024},
volume = {14},
number = {2},
pages = {112--132},
doi = {10.1016/j.prro.2023.11.001}
}
EUVIMED